Catalyst receives breakthrough designation for Firdapse

By BC Staff | Aug 27, 2013 | 11:55 PM GMT

Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) gained $0.59 (42%) to $2.01 on

Read the full 119 word article

How to gain access

Continue reading with a
two-week free trial.